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Abstract
Background: Smoking habits do not seem to be the main explanation of the epidemiological
characteristics of female lung cancer mortality in Asian countries. However, Asian countries are
often excluded from studies of geographical differences in trends for lung cancer mortality. We
thus examined lung cancer trends from 1971 to 1995 among men and women for 23 countries,
including four in Asia.
Methods: International and national data were used to analyze lung cancer mortality from 1971
to 1995 in both sexes. Age-standardized mortality rates (ASMR) were analyzed in five consecutive
five-year periods and for each five-year age group in the age range 30 to 79. The age-period-cohort
(APC) model was used to estimate the period effect (adjusted for age and cohort effects) for
mortality from lung cancer.
Results: The sex ratio of the ASMR for lung cancer was lower in Asian countries, while the sex
ratio of smoking prevalence was higher in Asian countries. The mean values of the sex ratio of the
ASMR from lung cancer in Taiwan, Hong Kong, Singapore, and Japan for the five 5-year period were
2.10, 2.39, 3.07, and 3.55, respectively. These values not only remained quite constant over each
five-year period, but were also lower than seen in the western countries. The period effect, for
lung cancer mortality as derived for the 23 countries from the APC model, could be classified into
seven patterns.
Conclusion: Period effects for both men and women in 23 countries, as derived using the APC
model, could be classified into seven patterns. Four Asian countries have a relatively low sex ratio
in lung cancer mortality and a relatively high sex ratio in smoking prevalence. Factors other than
smoking might be important, especially for women in Asian countries.
Background
Worldwide, over one million people die of lung cancer
each year [1]. In the US, lung cancer is the most common
cause of cancer deaths in both sexes [2], and mortality
rates in women have risen 500% since 1950 [3]. In the
European Union countries, although age-standardized
mortality rates have decreased for most cancer sites, lung
cancer mortality rates have significantly risen in women
[4]. A rising death rate from lung cancer has also been
observed in Taiwan. Between 1971 and 2001, age-stand-
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ardized lung cancer mortality rates per 100 000 per year in
Taiwan have increased sharply, from 12.66 to 32.93
among men and from 7.83 to 14.94 among women [5].
Today, in Taiwan, lung cancer is the leading cause of can-
cer death in women and the second leading cause in men
[5].
Epidemiological studies have shown that cigarette smok-
ing is the major cause of lung cancer in both sexes [6-8].
However, smoking habits do not seem to be the main
explanation of the epidemiological characteristics of
female lung cancer mortality in Asian countries [9-13],
where the prevalence of smoking is relatively low but lung
cancer mortality rates are relatively high. Factors other
than smoking habits might contribute to the variability in
lung cancer mortality.
Long-term geographical trends in cancer mortality can
provide useful information to assist etiological research.
However, Asian countries are often excluded from studies
of geographical differences in trends in lung cancer mor-
tality. In order to clarify the changing patterns of lung can-
cer mortality worldwide, we examined lung cancer trends
from 1971 to 1995 among men and women for 23 coun-
tries including four from Asia – Taiwan, Japan, Singapore,
and Hong Kong. In addition, we plotted the pattern of
mortality rate in these countries by using the age-period-
cohort (APC) model.
Methods
We used data from the World Health Organization
(WHO) and Taiwan to analyze secular trends from 1971–
1995 in lung cancer mortality in both men and women.
Mortality data provided by WHO were relatively incom-
plete in some countries, so we analyzed data from 22
countries and Taiwan. The twenty-two countries – Hong
Kong, Singapore, Japan, Portugal, Poland, Italy, Cuba,
Spain, Hungary, France, Greece, Finland, United States,
England and Wales, Netherlands, Belgium, Canada, Aus-
tralia, New Zealand, Denmark, Norway and Sweden – are
members of WHO. The data for Taiwan came directly
from the Office of Statistics, Department of Health in Tai-
wan. Since rates for the under 30-year age group are often
based on few deaths, and rates for the over 80-year group
might be affected by competitive death effects, only rates
for the age range 30 to 79 were considered, so as to ensure
adequate reliability of the estimates. Lung cancer mortal-
ity rates between 1971 and 1995 were analyzed in five
consecutive five year periods (1971–1975, 1976–1980,
1981–1985, 1986–1990, and 1991–1995) and in five
year age groups.
Statistical methods
Age-standardized mortality rates (ASMR) were calculated
using the world population for 1976 as the reference [14].
Percent changes in the ASMR were calculated as
[(ASMR1991–1995  - ASMR1971–1975) / (ASMR1971–1975)] ×
100.
In order to apply the APC model, the matrix of age-spe-
cific death rates was calculated for each 5-year calendar
period (from 1971–1975 to 1991–1995) and age group
(from 30–34 to 75–79). The effect of period of death in
the APC model was evaluated by a log-linear Poisson
model with a modified method as described by Osmond
and Gardner [15]. Briefly, the estimate of period effect
results from minimizing the weighted sum of the Eucli-
dean distances from the three possible two-factor models
(age/period; age/cohort; period/cohort). The weights used
in the minimization process were based on the goodness-
of-fit measures of each two-factor model. In this study,
these were taken as the inverse of the deviance statistics.
The sum of period effects were constrained to be zero.
These "effects" can be interpreted as logarithms of "rela-
tive" risks. These relative risks were estimated separately
for men and women. A computer program written in the
SAS/IML language [16] was developed to perform the
above calculations.
Results
Age-standardized mortality rates from lung cancer per 100
000 population per year in 23 countries for 1971 to 1995
are listed for men in Table 1 and for women in Table 2.
Trends in the ASMR varied by sex. From 1971 to 1995, in
men, the rates progressively increased in nine countries
(Portugal, Hungary, Taiwan, Spain, Poland, Japan, Nor-
way, France and Greece), progressively decreased in two
countries (England and Wales and Finland) and increased
then declined in the others. In women, rates increased
between 1971–1975 and 1991–1995 in 23 countries
except for Hong Kong, Cuba, and Spain, with the highest
increasing rate observed in the Netherlands (223.46%).
Table 3 shows the sex ratio (male:female) of the ASMR for
lung cancer for five consecutive five- year periods in 23
countries. The sex ratio was greater than one in each five-
year period, indicating that the ASMR from lung cancer
was higher in men than in women. Among the 23 coun-
tries, the trend in the sex ratio gradually decreased for the
whole period in most countries except for Spain, France,
Italy, Poland, Greece, Portugal, Hungary, Cuba and the
Asian countries. For example, in 1971–1975, the highest
sex mortality ratio was seen in the Netherlands with a sex
ratio of 17.95, the ratio then gradually decreasing to a
value of 4.75 by 1991–1995. The change in the sex ratio
of mortality in the Netherlands might be due to the
increase and then decrease in male lung cancer mortality
and simultaneously to the increase in female lung cancer
mortality. On the other hand, the ratio gradually
increased in Spain. This might be due to Spain having theBMC Public Health 2005, 5:22 http://www.biomedcentral.com/1471-2458/5/22
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Table 1: Age-standardized mortality rate (per100 000 person years) from lung cancer in males in 23 countries, 1971–1995
ASMR
Country 1971–1975 1976–1980 1981–1985 1986–1990 1991–1995 Percent 
increase*
Rank$
Portugal 31.88 40.51 45.96 54.40 59.48 86.57 1
Hungary 97.10 116.05 138.49 161.34 180.91 86.31 2
Taiwan 32.08 39.80 49.95 54.24 58.44 82.17 3
Spain 56.92 68.84 80.68 93.80 101.49 78.30 4
Poland 93.91 113.65 135.111 5 2 . 2 31 5 8 . 3 4 6 8 . 6 0 5
Japan 38.88 46.55 53.40 56.96 59.44 52.87 6
Norway 45.20 53.24 62.61 65.43 67.36 49.03 7
France 74.81 87.45 93.16 99.32 100.08 33.77 8
Greece 79.55 93.63 99.23 103.77 105.44 32.54 9
Italy 94.59 110.47 123.02 125.63 117.10 23.80 10
Hong Kong 94.96 118.63 116.24 116.89 110.13 15.97 11
Canada 96.68 108.38 116.23 118.13 107.71 11.42 12
USA 109.60 117.87 121.16 120.33 115.23 5.13 13
Denmark 101.45 109.36 116.83 113.21 103.74 2.26 14
Sweden 48.34 52.24 50.10 48.56 48.21 -0.27 15
Singapore 92.34 114.24 115.29 102.90 91.47 -0.95 16
Belgium 146.33 163.41 166.59 155.70 144.87 -1.00 17
Cuba 75.86 76.35 76.59 76.16 72.90 -3.90 18
Netherlands 151.10 162.14 160.49 148.73 129.40 -14.36 19
Australia 99.14 100.74 100.11 90.81 80.86 -18.44 20
New Zealand 99.81 104.55 100.52 93.07 79.31 -20.54 21
England and 
Wales
159.59 152.45 136.82 120.40 101.21 -36.58 22
Finland 142.74 142.51 126.97 105.58 90.20 -36.81 23
*percent increase (%) = 100 × (ASMR1991–1995 - ASMR1971–1975) / (ASMR1971–1975)
$ Rank by percent increase
Table 2: Age-standardized mortality rate (per100 000 person years) from lung cancer in females in 23 countries, 1971–1995
ASMR
Country 1971–1975 1976–1980 1981–1985 1986–1990 1991–1995 percent 
increase*
Rank$
Netherlands 8.42 11.06 15.46 20.80 27.24 223.46 1
Norway 8.86 11.02 15.61 21.21 26.42 198.24 2
Denmark 21.25 29.28 40.86 49.78 58.41 174.91 3
Canada 17.94 25.44 34.93 43.53 49.13 173.81 4
USA 24.96 33.85 43.41 51.50 56.51 126.46 5
Hungary 16.75 19.34 22.99 29.11 36.83 119.89 6
Sweden 11.36 13.47 16.96 20.68 24.50 115.72 7
Poland 11.40 13.66 16.41 19.68 22.90 100.83 8
Australia 14.91 19.70 23.61 26.47 28.47 90.99 9
Belgium 10.74 12.31 13.79 16.45 19.86 84.90 10
New Zealand 22.58 26.88 30.83 36.53 38.00 68.29 11
France 7.07 7.44 8.42 9.97 11.89 68.19 12
Finland 8.71 11.35 12.39 13.48 14.54 67.02 13
Taiwan 16.03 19.55 23.13 25.69 26.43 64.94 14
Italy 10.69 12.12 13.51 15.09 16.23 51.86 15BMC Public Health 2005, 5:22 http://www.biomedcentral.com/1471-2458/5/22
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the fourth highest increase in male lung cancer mortality
accompanied by a progressive decrease in female lung
cancer mortality from 1971–1975 through 1986–1990,
followed by a slight increase.
The mean values of the sex ratio of the ASMR from lung
cancer in Taiwan, Hong Kong, Cuba, Singapore, and
Japan were 2.10, 2.39, 2.78, 3.07, and 3.55, respectively,
with a range of 0.17 to 0.51 over the five-year periods.
These values were not only relatively constant over time,
but were also lower than seen in the western countries. For
example, the lowest sex ratio of 2.10 was seen in Taiwan,
with the sex ratio remaining a relatively constant value
over the entire period.
Only age is adjusted when the ASMR is calculated. How-
ever, both age and cohort effect are adjusted in the APC
model. The period effects for males and females from the
APC model applied to the data from the 23 countries
could be classified into seven patterns: 1) an increasing
England and 
Wales
30.45 35.75 40.06 43.52 42.84 40.68 16
Portugal 6.74 7.14 7.97 8.56 9.43 39.97 17
Japan 11.90 13.60 14.97 15.35 15.73 32.25 18
Greece 12.64 13.57 13.21 13.86 14.28 12.97 19
Singapore 29.66 34.34 37.07 36.01 31.25 5.36 20
Hong Kong 44.18 48.99 48.01 48.32 43.14 -2.34 21
Cuba 27.87 26.63 26.90 27.77 27.03 -3.02 22
Spain 8.54 7.99 7.32 7.01 7.58 -11.27 23
* percent increase(%) = 100 × (ASMR1991–1995 - ASMR1971–1975) / (ASMR1971–1975)
$ Rank by percent increase
Table 3: Sex ratio of the age-standardized mortality rate from lung cancer in 23 countries, 1971–1995
Ratio
Country 1971–1975 1976–1980 1981–1985 1986–1990 1991–1995 Mean Range Rank*
Belgium 13.62 13.27 12.08 9.46 7.29 11.15 6.33 1
Netherlands 17.95 14.67 10.38 7.15 4.75 10.98 13.20 2
Finland 16.40 12.56 10.25 7.83 6.20 10.65 10.20 3
Spain 6.66 8.62 11.02 13.39 13.39 10.62 6.73 4
France 10.58 11.76 11.06 9.97 8.42 10.36 3.34 5
Italy 8.85 9.12 9.11 8.33 7.21 8.52 1.91 6
Poland 8.24 8.32 8.23 7.73 6.91 7.89 1.41 7
Greece 6.30 6.90 7.51 7.49 7.39 7.12 1.21 8
Portugal 4.73 5.67 5.77 6.36 6.31 5.77 1.63 9
Hungary 5.80 6.00 6.03 5.54 4.91 5.66 1.12 10
Australia 6.65 5.11 4.24 3.43 2.84 4.45 3.81 11
Norway 5.10 4.83 4.01 3.09 2.55 3.92 2.55 12
England and 
Wales
5.24 4.26 3.42 2.77 2.36 3.61 2.88 13
Canada 5.39 4.26 3.33 2.71 2.19 3.58 3.20 14
Japan 3.27 3.42 3.57 3.71 3.78 3.55 0.51 15
New Zealand 4.42 3.89 3.26 2.55 2.09 3.24 2.33 16
Denmark 4.77 3.74 2.86 2.27 1.78 3.08 2.99 17
Sweden 4.26 3.88 2.95 2.35 1.97 3.08 2.29 18
Singapore 3.11 3.33 3.11 2.86 2.93 3.07 0.47 19
USA 4.39 3.48 2.79 2.34 2.04 3.01 2.35 20
Cuba 2.72 2.87 2.85 2.74 2.70 2.78 0.17 21
Hong Kong 2.15 2.42 2.42 2.42 2.55 2.39 0.40 22
Taiwan 2.00 2.04 2.16 2.11 2.21 2.10 0.21 23
*Rank by mean
Table 2: Age-standardized mortality rate (per100 000 person years) from lung cancer in females in 23 countries, 1971–1995 (Continued)BMC Public Health 2005, 5:22 http://www.biomedcentral.com/1471-2458/5/22
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Secular trend in the relative risk (RR) of dying from male and female lung cancer, 1971–1995, based on analyses using the age- period-cohort model in Taiwan, England and Wales, New Zealand, USA, Singapore, Spain and Cuba Figure 1
Secular trend in the relative risk (RR) of dying from male and female lung cancer, 1971–1995, based on analyses using the age-
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trend in both sexes, seen in Taiwan (Figure 1), Norway,
Japan, Hungary, and Portugal; 2) a sharply increasing
trend in women, with little change seen in men seen in
USA (Figure 1), Sweden, Poland, Italy, Canada, Belgium,
Denmark and France; 3) a sharply increasing trend in
women, and a sharply decreasing trend in men, seen in
New Zealand (Figure 1), Finland, Australia and Nether-
lands; 4) a more gradual increasing trend in women, but
a sharply declining trend in men, seen only in England
and Wales (Figure 1); 5) a decreasing trend in both sexes,
seen in Singapore (Figure 1) and Hong Kong; 6) a decreas-
ing and then a gradually increasing trend in women, but a
sharply increasing trend in men, seen in Spain (Figure 1)
and Greece; and 7) a relatively steady trend in both sexes,
seen only in Cuba (Figure 1). In most countries, the long-
term trend in the period effect as derived from the APC
model was similar to the trend of ASMR. It is worth noting
that the trend in the ASMR for female lung cancer
increased and then declined in Singapore and Hong Kong.
After adjusting for the cohort effect, however, a decreasing
trend in the period effect was observed in Singapore and
Hong Kong.
Discussion
We found that the sex ratio in lung cancer mortality varied
over time and geographically. After adjusting for age and
cohort effects, seven patterns could be identified using the
APC model, indicating that some countries had a similar
trend in lung cancer mortality.
Koo and Ho [17] indicated that smoking was a strong risk
factor in the west and worldwide where there were high
rates of smoking in men. We appreciate that lung cancer
mortality rates for a given year depend on smoking habits
over a period before that year; however, it is not possible
to get data on smoking prevalence before 1975 from
WHO. Therefore, based on the smoking prevalence
obtained from World Health Organization (Table 4), the
first, second, third, and fifth highest sex ratios
(male:female) of smoking prevalence among the 23 coun-
tries were in Taiwan, Hong Kong, Singapore, and Japan,
respectively. However, the sex ratios of ASMR from lung
cancer in the four Asian countries were significantly lower
than in the western countries. That is, the four Asian coun-
tries have a relatively low sex ratio in lung cancer mortality
and a relatively high sex ratio in smoking prevalence. This
fact is of particular interest.
Table 4: Smoking prevalence in males and females, and their sex ratio, in 23 countries
Country Prevalence
Male Female Male: female ratio Rank* Data source$
Taiwan 55.1 3.3 16.7 1 Adult (18 years & older), 1996
Hong Kong 27.1 2.9 9.3 2 Adult (15 years & older), 1998
Singapore 26.9 3.1 8.7 3 Adult (18–64 year olds), 1998
Portugal 30.2 7.1 4.3 4 Adult (15 years & older), 1995–1996
Japan 52.8 13.4 3.9 5 Adult (15 years & older), 1998
Poland 39.0 19.0 2.1 6 Adult, 1998
Italy 32.2 17.3 1.9 7 Adult (14 years & older), 1998
Cuba 48.0 26.3 1.8 8 Adult (15 years & older), 1995
Spain 42.1 24.7 1.7 9 Adult (16 years & older), 1997
Greece 46.0 28.0 1.6 10 Adult, 1994–1998
Hungary 44.0 27.0 1.6 11 Adult (18 years & older), 1998–1999
France 39.0 27.0 1.4 12 Adult (18 years & older), 1997
Finland 27.0 20.0 1.4 13 Adult (15–64 year olds), 1999
USA 27.6 22.1 1.3 14 Adult (18 years & older), 1997
Netherlands 37.0 30.0 1.2 15 Adult (15 years & older), 1998
Belgium 31.0 26.0 1.2 16 Adult (15 years & older), 1999
Canada 27.0 23.0 1.2 17 Adult (15 years & older), 1999
Australia 27.1 23.2 1.2 18 Adult (16 years & older), 1995
New Zealand 26.0 24.0 1.1 19 Adult (15 years & older), 1998
Denmark 32.0 30.0 1.1 20 Adult (14 years & older), 1998
England and Wales 29.0 28.0 1.0 21 Adult (16 years & older), 1996
Norway 33.7 32.3 1.0 22 Adult (16–74 year olds), 1998
Sweden 17.1 22.3 0.8 23 Adult (16–84 year olds), 1998
*Rank by Male: female ratio
$Data were obtained from the World Health OrganizationBMC Public Health 2005, 5:22 http://www.biomedcentral.com/1471-2458/5/22
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Dietary fat consumption has been found to be positively
related to lung cancer mortality [18-20]. Our data from
Japan, Taiwan and Cuba women (on Tables 2 and 5) also
indicated that the percent increase of fat consumption was
positively related to the percent increase of ASMR by using
the Spearman's rank correlation coefficient. Further study
of factors other than smoking, like fat intake, on lung can-
cer mortality seems warranted, especially for women in
Asian countries (Japan and Taiwan).
Conclusion
Period effects for both men and women in 23 countries,
as derived using the APC model, could be classified into
seven patterns. The four Asian countries have a relatively
low sex ratio in lung cancer mortality and a relatively high
sex ratio in smoking prevalence. Factors other than smok-
ing might be important, especially for women in Asian
countries.
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